Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 484-489, Vol. 37, No. 3
Veterans Administration Medical Center, Iowa
City, Iowa 52246,1 and
Departments of
Internal Medicine,2
Pathology,3 and
Preventive
Medicine,4 University of Iowa College of
Medicine, Iowa City, Iowa 52242
Received 22 September 1998/Returned for modification 9 November
1998/Accepted 30 November 1998
We previously demonstrated that whole blood contains significantly
more hepatitis C virus (HCV) RNA than plasma. To validate the
whole-blood-based HCV RNA detection method, a prospective comparison of
HCV RNA detection in whole blood and plasma from 50 patients with
chronic liver disease was undertaken. Whole-blood and plasma aliquots
were independently tested for HCV RNA by reverse transcriptase (RT) PCR
assay, and plasma was tested by the Roche Amplicor assay. HCV RNA was
detected in 35 of 50 (70%) whole-blood samples by RT-PCR but in only
26 of 50 (52%) plasma samples tested by the Amplicor assay
(P < 0.01). HCV RNA was detected in 85% of HCV
antibody-positive patients by the whole-blood method compared with 74%
of plasma samples by the Amplicor method. The five HCV antibody-positive subjects who were negative by whole-blood-based RT-PCR assay were all receiving interferon therapy and had normal transaminases at the time of testing. HCV RNA was detected in 38% of
HCV antibody-negative subjects by the whole-blood-based RT-PCR assay
compared with 6.25% of these patients by the Amplicor assay
(P < 0.05). There were nine samples in which HCV RNA
was detected in whole blood but the Amplicor test was negative. Eight of the nine RNAs prepared from these whole-blood samples tested positive in the Amplicor assay, thus confirming the specificity of our
results. This study demonstrates that whole-blood-based HCV RNA
detection is more sensitive than currently available commercial tests
and that whole-blood RNA is suitable for use in commercial assays.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis
C Virus RNA Detection Systems: Improved Detection Using Whole Blood
as the Source of Viral RNA


*
Corresponding author. Mailing address: University of
Iowa Hospitals and Clinics, Department of Internal Medicine, SW 54 GH, 200 Hawkins Dr., UIHC, Iowa City, IA 52242. Phone: (319) 356-3168. Fax:
(319) 356-4600. E-mail: jack-stapleton{at}uiowa.edu.
Present address: Shanghai RAAS Blood Product Co., Ltd.,
Shanghai, People's Republic of China.
Present address: Shanghai Institute of Biological Products,
Shanghai 200052, People's Republic of China.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|